Subscribe to Pharmaceutical Processing News

The Lead

Drug R&D Costs: $1.7 Billion And Rising

April 20, 2015 | by Institute For Policy Innovation | Comments

Growing costs have been attributed to a slow FDA, drug complexity, and short patent life.


ChemoCentryx Initiates Clinical Trial of Its Next-Generation CCR2 Inhibitor in Pancreatic Cancer

April 20, 2015 10:19 am | by Globe Newswire | Comments

CCX872 is the company's second clinical compound which is an orally administered inhibitor of the chemokine receptor known as CCR2.


Study Reveals Potential Treatment for Soldiers' Internal Injuries

April 17, 2015 4:55 pm | by Andy Szal, Digital Reporter | Comments

Explosions account for nearly 80 percent of today's combat-related injuries, and subsequent internal bleeding could prove fatal without quick intervention.


With Biosimilar Drug Development on The Rise, Researchers Explore Efficacy

April 17, 2015 4:51 pm | by Future Science Group | Comments

Immunotherapy review explores key questions on how biosimilar drug likenesses and differences will impact patient treatments.


Glaxo Recalls Flu Vaccine Due to Potency Problem

April 17, 2015 3:37 pm | by MATTHEW PERRONE, AP Health Writer | Comments

The company alerted U.S. customers Tuesday that the vaccine can lose potency and fail to adequately protect against some strains of the flu.


Survey: More Than Half of Older Adults in The US Now Taking Aspirin

April 17, 2015 3:05 pm | by Oregon State University | Comments

More than half of the older adults in the United States are now taking a daily dose of aspirin, even though its use is not recommended by the Food and Drug Administration for most people who have not yet had a heart attack or stroke.


USDA Veterinarian: Bird Flu Outbreak Could be 'Devastating'

April 17, 2015 3:02 pm | by STEVE KARNOWSKI, Associated Press | Comments

The nation's poultry industry may have to live with a deadly bird flu strain for several years, which would be "devastating," the U.S. Department of Agriculture's chief veterinary officer said Thursday.


Fed Grant for Pain-Free Blood Test Startup at UW

April 17, 2015 12:32 pm | by University of Wisconsin - Madison | Comments

A company with deep roots at the University of Wisconsin-Madison wants to make blood sampling less painful and more convenient.


Merck CEO Frazier Becomes PhRMA Board Chairman

April 17, 2015 12:25 pm | Comments

Kenneth C. Frazier, chairman and CEO of Merck & Co., Inc., was elected chairman of the Board of the Pharmaceutical Research and Manufacturers of America (PhRMA).


FDA Approves First Generic To Treat MS

April 17, 2015 12:16 pm | by FDA | Comments

The U.S. Food and Drug Administration today approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with relapsing forms of multiple sclerosis (MS).


Sartorius Stedim Biotech Acquires BioOutsource

April 17, 2015 12:10 pm | by Sartorius Stedim Biotech Group | Comments

Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.


PhRMA Applauds 2015 We Work For Health Award Winners

April 17, 2015 12:03 pm | by Pharmaceutical Research and Manufacturers of America (PhRMA) | Comments

PhRMA honored 13 employees from 12 biopharmaceutical companies as “We Work For Health Champions” for their extraordinary efforts in policy advocacy and community service.


Physicians Want Dr. Oz Gone From Columbia Medical Faculty

April 17, 2015 10:53 am | by Verena Dobnik, Associated Press | Comments

A group of top doctors has demanded Columbia University remove Dr. Oz, citing his "egregious lack of integrity" for promoting what they call "quack treatments."


CollabRx and Medytox Solutions Sign Definitive Merger Agreement

April 16, 2015 3:47 pm | by Globe Newswire | Comments

Medytox currently owns and operates several healthcare companies, including clinical testing laboratories, an electronic medical records provider, a laboratory information systems company and a medical billing company. CollabRx is a leading informatics company focused on the interpretation of complex molecular and genetic tests in cancer.


Sagent Pharmaceuticals Appoints Michael Logerfo as President

April 16, 2015 3:39 pm | by Globe Newswire | Comments

Sagent Pharmaceuticals, Inc., a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that its current EVP and Chief Legal Officer Michael Logerfo has been appointed President.


U.S. Marshals Seize Unapproved Drugs From Florida Distributor

April 16, 2015 3:31 pm | by | Comments

Stratus Pharmaceuticals marketed and distributed unapproved prescription drug products that were manufactured by Sonar Products, Inc., of Carlstadt, New Jersey.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.